Posts Tagged ‘ISCI’
Early Study Finds MGC018 Active in Resistant Skin Cancer
Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…
Read MorePancreatic Cancer Prevention and Warning Signs
Jennifer L. Gnerlich, MD, FACS, FSSO is a specialty care physician in general surgery and complex general surgical oncology at Inova Schar Cancer Institute. She specializes in upper Gastrointestinal (GI) cancers and carcinomatosis. With the recent deaths of Ruth Bader Ginsburg and Alex Trebek, more people want to know about pancreatic cancer. While not a…
Read MoreColorectal Cancer Screening Should Begin at Age 45
Arthur Winer, MD, is a specialty care physician at Inova Schar Cancer Institute. Dr. Winer is board-certified in internal medicine, hematology and medical oncology. He is a practicing gastrointestinal medical oncologist and has clinical interests in colorectal, esophageal, gastrointestinal, liver and pancreatic cancers. For decades, experts advised people to begin colorectal cancer screening at age…
Read MoreIs Radiation Necessary After Breast Cancer Surgery?
Ductal carcinoma in situ (DCIS) is a cancer that forms in the cells that line the milk ducts, and it accounts for 20% of new breast cancer diagnoses. The most common treatment is breast-conserving surgery to remove the cancerous tissue. While only a small percentage of women experience an invasive cancer event following surgery, radiation…
Read MoreRemote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study
The COVID-19 pandemic has spurred cancer teams to find new ways to care safely for patients with cancer, in particular outpatients who have tested positive for COVID-19 but do not require hospitalization. Inova Schar Cancer Institute’s physicians and advanced practice providers utilized a program called remote patient monitoring (RPM) to observe COVID-positive outpatients. To study…
Read MoreDiet and Exercise Guidelines for Cancer Prevention: How to Get Started
Lauren Fay, RD, CSO, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in oncology nutrition and nutrition support. The American Cancer Society (ACS) recently released new diet and activity guidelines to reduce cancer risk. Great, you might be thinking. One more thing I should be…
Read MoreInova Schar Cancer Institute Announces Plans to Open Cancer Screening and Prevention Center
Falls Church, VA – Inova Health System and its Inova Schar Cancer Institute today announced plans to open a new cancer screening and prevention center on the campus of the Inova Center for Personalized Health. The new 24,000 square-foot center, slated to open in 2022, is being made possible by the generous donation of $20…
Read MoreThe Evolving Role of Immunotherapy for Gastrointestinal Cancers
Raymond Wadlow, MD, is an oncologist at Inova Schar Cancer Institute. He is board-certified in Medical Oncology and Internal Medicine and has a special interest in gastrointestinal oncology. Immunotherapy is a relatively new type of cancer therapy — and for some cancers, it has been a game changer. Unfortunately, it’s been a bumpier road for…
Read MoreLaura Matthews, MBA, MPH Named as Vice President and Administrator of Inova Schar Cancer Institute
Inova Schar Cancer Institute is proud to announce that Laura Matthews, MBA, MPH, has been named as Inova Schar’s Vice President and Administrator. Laura joined Inova in 2014 as part of the strategic planning team before joining the Inova Schar team as Director of Operations and Growth in January 2018. She began working as the Acting…
Read MoreInova Schar Joins Worldwide Research Effort to Gather COVID-19 Data
Inova Schar has joined colleagues around the country and soon, around the world, as part of the COVID-19 and Cancer Consortium (CCC19), a group of over 100 cancer centers and other organizations who have come together to collect data with the common cause of understanding better the unique effects of COVID-19 on patients with cancer,…
Read More